5.20
肝硬変は、炎症が長引くこと、過剰な線維性再形成、再生障害によって引き起こされる進行性の慢性肝障害です。時間の経過とともに、繰り返される肝臓の構造や機能が乱され、血流減少、胆汁排出の障害、代謝能力の低下を引き起こします。
肝硬変の病態生理
肝硬変は、慢性肝障害に対する主な反応の3つ、すなわち炎症、免疫活性…
肝硬変は繰り返しの肝損傷から始まり、炎症、免疫システムの活性化、細胞死という3つの主要な過程を引き起こします。
これらのプロセスが重なり、進行性の肝障害を引き起こします。
炎症は免疫細胞を肝臓に引き寄せ、腫瘍壊死因子αやインターロイキン1などの炎症性サイトカインの放出を促します。
これらのサイトカインは線維化の主な推進因子である形質転換成長因子βの放出を刺激します。
免疫系の活性化は肝星状細胞を活性化させ、過剰なコラーゲンや細胞外マトリックスタンパク質を産生させます。
継続的な活性化は肝組織内に高密度な線維帯を蓄積させ、肝組織の正常構造を歪め、血流を妨げます。
これらの変化とともに肝細胞のアポトーシスと壊死が起こり、線維化の進行に伴い不規則な再生を引き起こします。
この再生の乱れにより、肝細胞の結節が高密度な線維化組織に囲まれます。
その結果、歪みが生じて門脈血流への抵抗が増し、門脈高血圧症を引き起こします。
View the full transcript and gain access to JoVE Core videos
Q1: What three main processes drive cirrhosis development?
Cirrhosis develops through inflammation, immune system activation, and hepatocyte death. Inflammation recruits immune cells that release cytokines like tumor necrosis factor-alpha and interleukin-1, triggering transforming growth factor-beta production. These processes activate hepatic stellate cells, stimulate collagen production, and cause liver cell death, collectively driving progressive liver damage and fibrosis.
Q2: How do hepatic stellate cells contribute to cirrhosis?
Hepatic stellate cells normally store vitamin A in a quiescent state. When activated by inflammatory signals, they transform into myofibroblasts and produce excess collagen and extracellular matrix proteins. Continuous activation leads to dense fibrous tissue accumulation that replaces normal liver tissue, distorting the liver's architecture and impairing its function.
Q3: What happens to the liver's structure as fibrosis progresses?
As fibrosis progresses, dense fibrous bands accumulate within liver tissue, distorting normal architecture. Hepatocyte death triggers disorganized regeneration, creating regenerative nodules—clusters of liver cells surrounded by fibrous tissue. These nodules further distort vascular and biliary structures, increasing resistance to portal blood flow and leading to portal hypertension.
Q4: How does cirrhosis lead to portal hypertension?
Fibrosis and regenerative nodules in the liver distort normal vascular architecture, increasing resistance to portal blood flow. This elevated pressure in the portal vein causes portal hypertension, which can trigger serious complications including ascites, splenomegaly, and bleeding from esophageal or gastric varices.
Q5: What role does inflammation play in cirrhosis pathophysiology?
Chronic liver injury triggers inflammation that recruits immune cells and promotes oxidative stress and reactive oxygen species production. Inflammatory cytokines damage liver tissue, disrupt cellular balance, and initiate fibrogenesis. This sustained inflammation accelerates hepatocyte injury and perpetuates the cycle of liver damage and fibrotic remodeling.
Q6: How does impaired liver regeneration affect cirrhosis progression?
Hepatocyte apoptosis and necrosis accelerate liver damage, prompting regeneration attempts. However, surrounding fibrosis disrupts this regenerative process, resulting in disorganized regeneration and regenerative nodules rather than normal tissue repair. This impaired regeneration perpetuates structural distortion and progressive functional decline in the liver.
Q7: What metabolic complications can result from advanced cirrhosis?
Advanced cirrhosis reduces the liver's ability to detoxify substances, allowing toxins like ammonia to accumulate and cause hepatic encephalopathy. The liver's diminished metabolic capacity also leads to kidney dysfunction, hormonal problems, and potential multi-organ failure in severe cases of decompensated cirrhosis.